AstraZeneca Vaccine Is Effective Against COVID-19, Phase III Study Says

Results of the trial, which involved more than 32,000 volunteers, showed two doses of the vaccine administered four weeks apart had an efficacy of 79% at preventing symptoms of COVID-19.

(Image credit: Finnbarr Webster/Getty Images)